44 related articles for article (PubMed ID: 31267379)
1. A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction.
Damaneh MS; Hu JP; Huan XJ; Song SS; Tian CQ; Chen DQ; Meng T; Chen YL; Shen JK; Xiong B; Miao ZH; Wang YQ
Invest New Drugs; 2020 Jun; 38(3):700-713. PubMed ID: 31267379
[TBL] [Abstract][Full Text] [Related]
2. The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis.
Feng Z; Xia Y; Gao T; Xu F; Lei Q; Peng C; Yang Y; Xue Q; Hu X; Wang Q; Wang R; Ran Z; Zeng Z; Yang N; Xie Z; Yu L
Cell Death Dis; 2018 Sep; 9(10):1006. PubMed ID: 30258182
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic Targeting of Histone H3K27 Acetylation/BRD4-dependent Induction of ALDH1A3 for Early-phase Drug Tolerance of Gastric Cancer.
Lee J; Mashima T; Kawata N; Yamamoto N; Morino S; Inaba S; Nakamura A; Kumagai K; Wakatsuki T; Takeuchi K; Yamaguchi K; Seimiya H
Cancer Res Commun; 2024 May; 4(5):1307-1320. PubMed ID: 38669046
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer.
Hashimoto M; Masuda T; Nakano Y; Tobo T; Saito H; Koike K; Takahashi J; Abe T; Ando Y; Ozato Y; Hosoda K; Higuchi S; Hisamatsu Y; Toshima T; Yonemura Y; Hata T; Uemura M; Eguchi H; Doki Y; Mori M; Mimori K
Cancer Sci; 2024 Jun; 115(6):1866-1880. PubMed ID: 38494600
[TBL] [Abstract][Full Text] [Related]
5. The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes.
Yu J; Yang Y; Zhou R; Tao Y; Zhu F; Jiao W; Zhang Z; Ji T; Li T; Fang F; Xie Y; Wu D; Zhuo R; Li X; Chen Y; Yin H; Wang J; Pan J
Carcinogenesis; 2024 Jun; 45(6):424-435. PubMed ID: 38302114
[TBL] [Abstract][Full Text] [Related]
6. Co-inhibition of BET and NAE enhances BIM-dependent apoptosis with augmented cancer therapeutic efficacy.
Zhang Q; Wu Q; Huan XJ; Song SS; Bao XB; Miao ZH; Wang YQ
Biochem Pharmacol; 2024 May; 223():116198. PubMed ID: 38588830
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative activities of sinigrin on carcinogen-induced hepatotoxicity in rats.
Jie M; Cheung WM; Yu V; Zhou Y; Tong PH; Ho JW
PLoS One; 2014; 9(10):e110145. PubMed ID: 25329483
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of BET and HAT/p300 suppresses colorectal cancer via DR5- and p53/PUMA-mediated cell death.
Kuang C; Tong J; Ermine K; Cai M; Dai F; Hao S; Giles F; Huang Y; Yu J; Zhang L
Front Oncol; 2022; 12():1018775. PubMed ID: 36313707
[TBL] [Abstract][Full Text] [Related]
9. Anticancer Effects of BRD4 Inhibitor in Epithelial Ovarian Cancer.
Kim Y; Park WH; Suh DH; Kim K; No JH; Kim YB
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473320
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Potential of Bromodomain and Extra-Terminal Domain Inhibitors for Synovial Sarcoma Cells.
Kotani Y; Imura Y; Nakai S; Chijimatsu R; Takami H; Inoue A; Mae H; Takenaka S; Outani H; Okada S
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539460
[TBL] [Abstract][Full Text] [Related]
11. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells.
Fonseca P; Cui W; Struyf N; Tong L; Chaurasiya A; Casagrande F; Zhao H; Fernando D; Chen X; Tobin NP; Seashore-Ludlow B; Lundqvist A; Hartman J; Göndör A; Östling P; Holmgren L
J Exp Clin Cancer Res; 2024 Apr; 43(1):107. PubMed ID: 38594748
[TBL] [Abstract][Full Text] [Related]
12. Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse.
Chen M; Mainardi S; Lieftink C; Velds A; de Rink I; Yang C; Kuiken HJ; Morris B; Edwards F; Jochems F; van Tellingen O; Boeije M; Proost N; Jansen RA; Qin S; Jin H; Koen van der Mijn JC; Schepers A; Venkatesan S; Qin W; Beijersbergen RL; Wang L; Bernards R
Cell Rep Med; 2024 Mar; 5(3):101471. PubMed ID: 38508142
[TBL] [Abstract][Full Text] [Related]
13. Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction.
Yin M; Guo Y; Hu R; Cai WL; Li Y; Pei S; Sun H; Peng C; Li J; Ye R; Yang Q; Wang N; Tao Y; Chen X; Yan Q
Nat Commun; 2020 Apr; 11(1):1833. PubMed ID: 32286255
[TBL] [Abstract][Full Text] [Related]
14. Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis.
Zhang MY; Liu SL; Huang WL; Tang DB; Zheng WW; Zhou N; Zhou H; Abudureheman T; Tang ZH; Zhou BS; Duan CW
Med Sci Monit; 2020 Apr; 26():e923411. PubMed ID: 32266878
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies.
Jiang F; Wei Q; Li H; Li H; Cui Y; Ma Y; Chen H; Cao P; Lu T; Chen Y
Bioorg Med Chem; 2020 Jan; 28(1):115181. PubMed ID: 31767403
[TBL] [Abstract][Full Text] [Related]
16. Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers.
Li MZ; Meng T; Song SS; Bao XB; Ma LP; Zhang N; Yu T; Zhang YL; Xiong B; Shen JK; Miao ZH; He JX
Invest New Drugs; 2021 Oct; 39(5):1213-1221. PubMed ID: 33710464
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells.
Liu Y; Xue M; Cao D; Qin L; Wang Y; Miao Z; Wang P; Hu X; Shen J; Xiong B
Genomics; 2021 May; 113(3):1057-1069. PubMed ID: 33667649
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer.
Zhang N; Tian YN; Zhou LN; Li MZ; Chen HD; Song SS; Huan XJ; Bao XB; Zhang A; Miao ZH; He JX
Cell Death Dis; 2021 Feb; 12(2):183. PubMed ID: 33589588
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations in
Chen HD; Guo N; Song SS; Chen CH; Miao ZH; He JX
Am J Cancer Res; 2020; 10(9):2813-2831. PubMed ID: 33042619
[TBL] [Abstract][Full Text] [Related]
20. Identification of drug responsible glycogene signature in liver carcinoma from meta-analysis using RNA-seq data.
Koreeda T; Honda H
Glycoconj J; 2024 Apr; 41(2):133-149. PubMed ID: 38656600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
